Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Respivert Limited patents

Recent patent applications related to Respivert Limited. Respivert Limited is listed as an Agent/Assignee. Note: Respivert Limited may have other listings under different names/spellings. We're not affiliated with Respivert Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Respivert Limited-related inventors

1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase inhibitors

There is provided a compound of formula (i) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and copd.. . ... Respivert Limited

Pyrazolyl ureas as kinase inhibitors

There are provided compounds of formula (i) as defined in the specification which are p38 map kinase inhibitors for use as medicaments for the treatment inter alia of inflammatory diseases.. . ... Respivert Limited

Inhibitors of hemopoietic cell kinase (p-59-hck) and their use in the treatment of influenza infection

The present invention relates inter alia to the treatment or prevention of influenza virus infection (including subtypes influenza a virus, influenza b virus, avian strain h5n1, a/h1n1, h3n2 and/or pandemic influenza) using compounds which inhibit the activity of p59-hck and to a method of screening for a candidate drug substance intended to prevent or treat influenza virus infection in a subject, said method comprising identifying a test substance capable of inhibiting p59-hck activity.. . ... Respivert Limited

Crystalline pl3 kinase inhibitors

. . There is provided inter alia 6-(2-((4-amino-3-(3-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl) methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-di hydroquinazolin-5-yl)-n, n-bis(2-methoxyethyl)hex-5-ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also provided dry powder pharmaceutical compositions for inhalation containing such solid crystalline forms.. ... Respivert Limited

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Respivert Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Respivert Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by